Metsera responds to Pfizer lawsuit, defends board process in Novo bid dispute
Pfizer’s GLP-1 lawsuit tests biosimilar ambitions and contract guardrails.
Dealstreet
Novo’s unsolicited bid for Metsera challenges Pfizer pact
Novo’s unsolicited Metsera bid could upend Pfizer pact and reshape the GLP-1 race.
Thermo Fisher’s Inspiring $10 Billion Acquisition of Clario
Thermo Fisher acquisition hits billion mark for Clario.
Novartis secures triumphant $12 billion takeover of Avidity
The billion-dollar acquisition advances Avidity’s RNA platform with momentum.
Biogen Secures Breakthrough Edge in Immunology with $1B Vanqua Buy
Biogen strengthens Immunology pipeline through $1B Vanqua acquisition deal.
Pfizer Throws Down $7.3B Gauntlet in Obesity Race with Metsera Buyout
After internal setbacks, Pfizer is buying its way into the obesity drug market.
The Big Bet: Health Care Deal Spotlight for September 1 to 7, 2025)
Healthcare deal spotlight September 1 to 7, 2025
Kymera Strikes License Agreement Deals With Sanofi, Gilead
Sanofi, Gilead sign License Agreement with Kymera for protein degrader programs.
Vor Bio and RemeGen Seal $4B Global License Agreement
Vor Bio, RemeGen sign Global License Agreement for RC98 development.
Novartis Inks $750M Flagship Pact for Cardio Innovation
Novartis makes a $750M flagship pact to address cardiovascular disease innovation.